# Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients

> **NCT07274345** · — · NOT_YET_RECRUITING · sponsor: **Amira Mohamed Zidan** · enrollment: 2000 (estimated)

## Conditions studied

- Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07274345
- **Lead sponsor:** Amira Mohamed Zidan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07274345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07274345, "Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07274345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*